James Casey Dalton Forward

All filings by James Casey Dalton Forward on record concern LeenLife Pharma International Inc. In total, 4 filings cover trades dated from 20 August 2015 to 14 December 2016.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 22 December 2016, reports a transaction in LeenLife Pharma International Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.